Alerts will be sent to your verified email
Verify Email
GCMCOMM
|
GCM Commodity
|
Amerise Biosciences
|
Superior Finlease
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-15.82 % | -0.33 % | 3.87 % |
|
5yr average Equity Multiplier
|
2.02 | 1.37 | 9.86 |
|
5yr Average Asset Turnover Ratio
|
0.04 | 0.15 | 0.02 |
|
5yr Avg Net Profit Margin
|
-18.54 % | 1.22 % | 18.21 % |
|
Price to Book
|
0.68 | 0.75 | 0.77 |
|
P/E
|
0.0 | 105.71 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 0.0 |
|
Inventory Days
|
919.16 Days | 0.0 | 0.0 |
|
Days Receivable
|
0.0 | 0.0 | 0.0 |
|
Days Payable
|
-52.25 Days | 27.62 Days | 6.9 Days |
|
5yr Average Interest Coverage Ratio
|
-67.54 | -378.51 | 247.42 |
|
5yr Avg ROCE
|
-16.77 % | -0.34 % | 5.93 % |
|
5yr Avg Operating Profit Margin
|
-38.6 % | -0.04 % | 2.49 % |
|
5 yr average Debt to Equity
|
0.0 | 0.01 | 8.79 |
|
5yr CAGR Net Profit
|
n/a | n/a | -36.9 % |
|
5yr Average Return on Assets
|
-5.7 % | -1.23 % | 0.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.74 % | 0.0 | 3.06 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 3.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
GCM Commodity
|
Amerise Biosciences
|
Superior Finlease
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|